Strengthening conflict-of-interest policies in medicine

Journal of Evaluation in Clinical Practice

Volumn 16, Issue 1, 2010, Pages 21-24

  Cosgrove, Lisa ^a   Bursztajn, Harold J ^b  

^a UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Conflict of interest; Disclosure policies in medicine

Indexed keywords

BIOMEDICINE; CONFLICT OF INTEREST; CONTINUING EDUCATION; CRITICAL THINKING; DRUG INDUSTRY; EDUCATION PROGRAM; EVIDENCE BASED PRACTICE; FINANCIAL MANAGEMENT; FUNDING; HEALTH CARE POLICY; HUMAN; INFORMATION DISSEMINATION; INTERPERSONAL COMMUNICATION; JOB SATISFACTION; MANAGEMENT; MEDICAL EDUCATION; MEDICAL PROFESSION; MEDICAL SOCIETY; PHYSICIAN ATTITUDE; PHYSICIAN INCOME; PRACTICE GUIDELINE; PRIORITY JOURNAL; SALARY; SHORT SURVEY; UNIVERSITY HOSPITAL;

CONFLICT OF INTEREST; DISCLOSURE; EDUCATION, MEDICAL, CONTINUING; ETHICS, RESEARCH; EVIDENCE-BASED MEDICINE; FINANCIAL SUPPORT; HUMANS; PRACTICE GUIDELINES AS TOPIC; UNITED STATES;

EID: 77149150314     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2009.01106.x     Document Type: Short Survey

References (27)

1. Thompson, D. F. (1993) Understanding financial conflicts of interest. New England Journal of Medicine, 329 (8 573 576.
2. Bekelman, J. E., Li, Y. Gross, C. P. (2003) Scope and impact of financial conflicts of interest in biomedical research. Journal of the American Medical Association, 289 (4 454 465.
3. Avorn, J. (2006) Dangerous deception - hiding the evidence of adverse drug effects. New England Journal of Medicine, 355 (21 2169 2171.
4. Chan, A. W., Hóbjartsson, A., Haahr, M. T. Gøtzsche, P. C. (2004) Empirical evidence for selective reporting of outcomes in randomized trials comparison of protocols to published articles. Journal of the American Medical Association, 289 (20 2457 2465.
5. Flanagin, A., Fontanarosa, P. B. DeAngelis, C. D. (2006) Update on JAMA's conflict of interest policy. Journal of the American Medical Association, 296, 220 221.
6. Horton, J. A., Collingridge, R., MConnell, D. Butcher, J. (2004) The Lancet's policy on conflict of interest. Lancet, 363 (9402 2 3.
7. Lewis, D. A., Michels, R., Pine, D. S., Schultz, S. K., Tamminga, C. A. Freedman, R. (2006) Conflict of interest. American Journal of Psychiatry, 163 (4 571 573.
8. Cosgrove, L. Bursztajn, H. J. (2006) Undoing undue industry influence: lessons from psychiatry as psychopharmacology. Journal of Organizational Ethics, 3, 131 133.
9. APA Press Release (2008) APA Names DSM-V Work Group Members: Experts to Revise Manual for Diagnosis of Mental Disorders. Arlington, VA : APA Press Release. May 1.
10. Cosgrove, L., Krimsky, S., Vijayraghavan, M. Schneider, L. (2006) Financial ties between DSM-IV panel members and the pharmaceutical industry. Psychotherapy and Psychosomatics, 75 (3 154 160.
11. Smith, W. R. (2007) Pseudo-evidence based medicine: what it is and what can be done about it. Clinical Governance: An International Journal, 12 (1 42 52.
12. Angell, M. (2004) The Truth about Drug Companies: How They Deceive Us and What to Do about It. New York : Random House.
13. Friedberg, M., Saffran, B., Stinson, T. J., Nelson, W. Bennett, C. L. (1999) Evaluation of conflict of interest in economic analyses of new drugs used in oncology. Journal of the American Medical Association, 282 (15 1453 1457.
14. Heres, S., Davis, J., Maino, K., Jetzinger, E., Kissling, W. Leucht, S. (2006) Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second generation antipsychotics. American Journal of Psychiatry, 2006 (2 185 194.
15. Krimsky, S. (2003) Science in the Private Interest. Lanham, MD : Rowman Littlefield Pub. Co.
16. Safer, D. J. (2002) Design and reporting modifications in industry sponsored comparative psychopharmacology trials. Journal of Nervous and Mental Disorders, 190 (9 583 592.
17. Ashar, B. H., Miller, R. G., Getz, K. J. Powe, N. R. (2004) Prevalence and determinants of physician participation in conducting pharmaceutical- sponsored clinical trials and lectures. Journal of General Internal Medicine, 19 (11 1140 1145.
18. Medical Professionalism Project (2002) Medical professionalism in the new millennium: a physician charter. Annals of International Medicine, 136 (3 243 246.
19. Chew, L. D., O'Young, T. S., Hazlet, T. K., et al. (2000) A physician survey of the effect of drug sample availability on physicians' behavior. Journal of General Internal Medicine, 15 (7 478 483.
20. Brennan, T. A., Rothman, D. J., Blank, L., et al. (2006) Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. Journal of the American Medical Association, 295 (4 429 433.
21. Brodkey, A. C. (2005) The role of the pharmaceutical industry in teaching psychopharmacology: a growing problem. Academic Psychiatry, 29 (2 222 229.
22. Marshall, J. Aldhous, P. (2006) Patient groups special: swallowing the best advice? New Scientist, 2575, 18 22.
23. Genuis, S. K. Genuis, S. J. (2006) Exploring the continuum: medical information to effect clinical practice. Paper I: the translation of knowledge into clinical practice. Journal of Evaluation in Clinical Practice, 12 (1 49 62.
24. Bursztajin, H. J., Chanowitz, B., Gutheil, T. G. Hamm, R. M. (1992) Micro-effects of language on risk perception in drug prescribing behavior. Bulletin of the American Academic Psychiatry Law, 20 (1 59 66.
25. Vieta, E. (2007) Psychiatry: from interests in conflicts to conflicts of interest. World Psychiatry, 6 (1 27 29.
26. Buetow, S., Upshur, R., Miles, A. Laughlin, M. (2006) Taking stock of evidence-based medicine: opportunities for its continuing evolution. Journal of Evaluation in Clinical Practice, 12 (4 399 404.
27. Bursztajn, H. J., Feinbloom, R. I., Hamm, R. M. Brodsky, A. (1981/2001) Medical Choices, Medical Chances: How Patients, Families, and Physicians Can Cope with Uncertainty. New York : Delacorte Press/Seymour Lawrence.